Opioid analgesics drug abuse

These differences in the behavioural properties of the opioid receptor sub-types are of considerable interest because the clinical use of currently marketed opioid analgesic drugs is limited by their undesirable side-effects, which include respiratory depression, constipation and an abuse or dependence liability. These side-effects have been associated with mu receptor ac-... 

Non-steroidal antiinflammatory drugs (NSAIDs) are also known as nonopioid analgesics. They relieve pain without interacting with opioid receptors and do not depress CNS and have no drug dependence or drug abuse property and possess antipyretic activity also. They act primarily on peripheral pain mechanisms and also in CNS to raise pain threshold. 

Despite worry over the potential for addiction, opioid use for medical purposes has been increasing in recent years for most narcotic analgesics. However, despite the overall increase in the use of opioids for legitimate medical reasons, drug abuse among legitimate users has fallen during this period of time. 

The increased vigilance of legal authorities to crack down on prescription drug abuse has led to situations where patients are afraid to ask for sufficient pain medication for fear of being seen as an addict or someone with a low pain threshold. Many physicians are afraid to prescribe opioids because they are required by law to record and justify all narcotic analgesic prescriptions. 

In the United States and other developed countries, illicit opium derivatives such as heroin or licit synthetic opioids such as Vicodin have generally replaced the use of smoked or eaten opium. According to Drug Abuse Warning Network (DAWN) data provided by the Substance Abuse and Mental Health Services Administration (SAMHSA), there were more than 82,000 emergency department admissions for narcotic analgesics/narcotic analgesic combinations in 2000. Only 167 of these visits were for opium and opium combinations. 

Obviously, the risk of causing dependence is an important consideration in the therapeutic use of these drugs. Despite that risk, under no circumstances should adequate pain relief ever be withheld simply because an opioid exhibits potential for abuse or because legislative controls complicate the process of prescribing narcotics. Furthermore, certain principles can be observed by the clinician to minimize problems presented by tolerance and dependence when using opioid analgesics ... 

Diamorphine Diamorphine is relatively unstable in aqueous solutions, and minimum decomposition was observed at pH 4. Preparations should be used within 4 weeks when kept at room temperature, but degradation products also have analgesic activity.45,46 Diamorphine is used in the management of opioid dependence this is also a drug of abuse and the overdose is fatal47,48 Interactions are similar to those of opioid analgesics. Withdrawal symptoms of opioid dependence can be treated with diamorphine and methadone.49... 

Fentanyl and its analogs are drugs of abuse. Overdose and dependence may lead to respiratory complications and death.58 Adverse effects can be treated with drugs such as naloxone, atropine, and neuromuscular blockers. In general, interactions are similar to those of opioid analgesics. 

RECEPTOR ANTAGONIST (channel-blocking at NMDA receptors). It is an OPIOID ANALGESIC, (dissociate) GENERAL ANAESTHETIC, PSYCHOTROPIC and ANTICONVULSANT. It iS a drug of abuse and has been withdrawn from human clinical use. etidocaine [ban, inn, usan] (Duranest ) is an amide series LOCAL ANAESTHETIC, used by injection for infiltration and regional pain relief. 

Prescription regulations for most CNS drugs are based on their abuse liability. The potent opioid analgesics (e.g., morphine, methadone, meperidine, fentanyl) are judged to have the highest potential for abuse, along with CNS stimulants (e.g., amphetamine, cocaine) and short-acting barbiturate (e g., secobarbital). No refills or telephone prescriptions are permissible. 

Answer B. Buspirone has selective anxiolytic activity that is slow in onset The drug has no abuse liability and will not suppress withdrawal symptoms in patients who have become physically dependent on barbiturates, benzodiazepines, or ethanol. Bupropion is an antidepressant, also approved for management of dependence on nicotine. Baclofen is a spinal cord muscle relaxant that activates GABAfi receptors. Buprenorphine is a long-acting opioid analgesic with no effectiveness in GAD, and butabarbital is a barbiturate that may cause dependence. 

---